Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,059,412 | 3,703,450 | 2,635,304 | 1,729,728 | 822,263 |
| Depreciation Amortization | N/A | 465,350 | N/A | N/A | N/A |
| Accounts receivable | N/A | -50,112 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 98,150 | N/A | N/A | N/A |
| Other Working Capital | -323,030 | 278,726 | -111,955 | -298,598 | -101,901 |
| Other Operating Activity | 515,715 | -656,986 | 956,321 | 769,996 | 498,753 |
| Operating Cash Flow | $1,252,097 | $3,838,579 | $3,479,670 | $2,201,126 | $1,219,115 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 88,373 | -86,573 | 1,681 | 129,600 | -141,040 |
| PPE Investments | -138,492 | -573,523 | -388,815 | -236,909 | -90,971 |
| Purchase Sale Intangibles | -19,481 | -43,200 | -25,215 | -9,677 | -5,818 |
| Other Investing Activity | -19,481 | -43,200 | -25,215 | -9,677 | -5,818 |
| Investing Cash Flow | $-69,600 | $-703,296 | $-412,349 | $-116,986 | $-237,829 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | -86,746 | N/A | N/A | N/A |
| Common Stock Repurchased | -507,392 | -2,055,629 | -1,796,989 | -1,504,915 | -498,576 |
| Dividend Paid | -1,720,526 | -1,337,818 | -1,301,430 | -1,337,818 | -1,364,915 |
| Other Financing Activity | 304,789 | 1 | 0 | 0 | 0 |
| Financing Cash Flow | $-1,923,129 | $-3,480,192 | $-3,098,419 | $-2,842,733 | $-1,863,491 |
| Exchange Rate Effect | 2,302 | -1,382 | 3,866 | 2,419 | -529 |
| Beginning Cash Position | 1,957,486 | 2,256,250 | 2,194,882 | 2,256,250 | 2,301,949 |
| End Cash Position | 1,219,156 | 1,909,958 | 2,167,649 | 1,500,077 | 1,419,215 |
| Net Cash Flow | $-738,330 | $-346,291 | $-27,232 | $-756,173 | $-882,734 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,252,097 | 3,838,579 | 3,479,670 | 2,201,126 | 1,219,115 |
| Capital Expenditure | -139,201 | -582,682 | -391,673 | -239,501 | -93,086 |
| Free Cash Flow | 1,112,896 | 3,255,897 | 3,087,997 | 1,961,625 | 1,126,029 |